T cells orchestrate inflammation in multiple sclerosis, an inflammatory disorder of the CNS resulting in demyelination, oligodendrocyte loss, and axonal damage (1, 2) . Calcium signals control proliferation, differentiation, apoptosis, and a variety of transcriptional programs and effector functions of T cells (3) (4) (5) . Conversely, disturbed Ca 2+ signaling and dysregulation of the intracellular Ca 2+ network in T lymphocytes have been associated with inflammatory and autoimmune disorders, including multiple sclerosis (6) .
Signaling cascades after TCR stimulation involve phospholipase C-mediated cleavage of phosphotidylinositol 4,5-bisphosphate into diacylglycerol and 1,4,5-inositol trisphosphate, which triggers Ca 2+ release from the endoplasmic reticulum through 1,4,5-inositol trisphosphate receptor channels and leads to a transient elevation of the cytosolic Ca 2+ concentration (7) . This Ca 2+ store depletion is followed by Ca 2+ entry through specialized Ca 2+ release-activated calcium channels in the plasma membrane, resulting in longerlasting (∼1 h) elevated cytosolic Ca 2+ concentration, which is mandatory for transcription-dependent steps of T cell activation (8, 9) . This so-called store-operated calcium entry (SOCE) occurs through the four-transmembrane channel, Orai1, (6, 10, 11) and is regulated by the endoplasmic reticulum-resident calcium sensor molecule stromal interaction molecule (STIM) 1, which connects store depletion to the opening of the channel (12) . The closely related STIM2 has been shown to regulate basal cytosolic and store Ca 2+ concentrations in different cell types (13) . The recent generation of mice lacking STIM molecules in T cells confirmed the essential function of STIM1 for SOCE (12, 14) and also revealed the contribution of STIM2 to this process (15) . The significance of SOCE for T cell function in vivo, however, has not been definitively addressed to date despite the recent description of human immunodeficiency syndromes associated with deficiencies in STIM1 function (16) . A first study has revealed that STIM1-deficient T cells display defects in homeostatic T cell proliferation but, despite abolished SOCE, are able to support humoral immune responses after vaccination and can induce acute graft-versus-host disease following adoptive transfer into allogeneic hosts (12) . In contrast, the significance of STIM-dependent SOCE for inflammatory reactions in vivo has remained elusive.
Inthisstudy,weinvestigate thecontribution of STIM1 and STIM2 in a model of autoimmune CNS inflammation, myelin oligodendrocyte glycoprotein (MOG 35-55 ) peptide-induced experimental autoimmune encephalomyelitis (EAE). We show that STIM1 deficiency abrogates disease development, whereas STIM2 deficiency significantly delays onset and attenuates the clinical course of MOG EAE. These findings provide a strong rationale for considering STIM molecules as potential new pharmacological targets in T cell-mediated disorders.
Materials and Methods

Mice
The generation of Stim1 2/2 bone marrow (BM) chimeric mice has been described previously (17) . Stim1 2/2 BM chimeric mice or equally treated wild-type (wt) mice were used 11-20 wk after transplantation. The generation of Stim2 2/2 mice has been reported recently (18) . Genotypes were determined by PCR analysis using the following primer pairs: Stim2 wt allele forward primer 59-CCCATATGTAGATGTGTTCAG-39; reverse primer 59-GAGTGTTGTTC-CCTTCACAT-39; Stim2 knockout allele forward primer 59-TTATCGATGAGCGTGGTGGTTATGC-39; reverse primer 59-GCGCGTACATCGGGCAAATAATATC-39. All animal experiments were approved by local authorities and conducted according to the German law of animal protection.
Induction and evaluation of EAE
EAE was induced by immunization of female Stim1
2/2 BM chimeras, Stim2 2/2 mice, and corresponding wt littermates with 200 mg myelin oligodendrocyte glycoprotein (MOG 35-55 ) peptide (Biotrend, Cologne, Germany). CFA was supplemented with MOG to obtain a 1 mg/ml emulsion and 23 100 ml were injected s.c. at two different sites of the flank of deeply anesthesized mice. Pertussis toxin was injected on the day of immunization and 2 d later (400 ng, Alexis, San Diego, CA). All animals were kept under standard conditions and had access to water and food ad libidum.
The clinical course of EAE was monitored using following score system: grade 0, no abnormality; grade 1, limp tail tip; grade 2, limp tail; grade 3, moderate hind limb weakness; grade 4, complete hind limb weakness; grade 5, mild paraparesis; grade 6, paraparesis; grade 7, heavy paraparesis or paraplegie; grade 8, tetraparesis; grade 9, quadriplegia or premoribund state; grade 10, death.
Western blot analysis of STIM expression in lymph node cells
Whole protein lysates were separated by SDS-PAGE gel and blotted onto a polyvinylidene difluoride membrane. Anti-STIM1 Ab from Abnova (H00006786-M01; Abnova, Taipei, Taiwan), and anti-STIM2 (CT) Ab from ProSci (catalog no. 4123; ProSci, Poway, CA) were used. STIM expression was normalized according to a-tubulin expression using rat anti-mouse a-tubulin Ab (MAB1864; Chemicon, Hofheim, Germany).
Proliferation assay-[ 3 H]thymidine uptake
Splenocytes were isolated by standard procedures. In brief, 1 3 10 5 splenocytes from wt, Stim1 2/2 chimeric, and Stim2 2/2 mice were cultured for 3 d after isolation and stimulated with CD3/CD28 beads (cell to bead ratio 2:1; Dynal Biotech, Hamburg, Germany). A total of 1 mCi of [ 
Cytokine production
Splenocytes from wt, Stim1 2/2 chimeric, and Stim2 2/2 mice were isolated from naive mice and at the disease maximum (day 15), and 3 3 10 6 splenocytes in 1 ml medium were plated for 48 h in DMEM containing 10 mM HEPES, 25 mg/ml gentamicin, 50 mM mercaptoethanol, 5% FCS, 2 mM glutamine, and 1% nonessential amino acids (Cambrex, Verviers, Belgium). Splenocytes were either left unstimulated or were stimulated with MOG peptide (10 mg/ml) or CD3/CD28 beads, and supernatants were assessed for IFN-g, IL-2, IL-4, IL-5, IL-10, and IL-17 protein levels by ELISA (R&D Systems, Wiesbaden, Germany) or by cytokine bead array (Bender MedSystems, Vienna, Austria) according to the manufacturer's instructions. For ELISPOT assays, 1 3 10 5 splenocytes per well were cultured with 20 mg/ml MOG peptide in 96-well plates according to the manufacturer's instructions (MABTECH, Hamburg, Germany). Spots were evaluated by CTL Europe (Bonn, Germany).
Immunotyping and analysis of Ag presentation
Analysis of T cell subtype distribution and APCs by flow cytometry was done as previously described (19) using appropriate Abs or isotype controls (all by BD Biosciences, San Jose, CA): rat anti-mouse CD4-PerCP (no. 553052), rat anti-mouse CD8a-PE (no. 553033), rat anti-mouse CD44-FITC (no. 553133), rat anti-mouse CD62L-APC (no. 553152), rat anti-mouse CD11b-PerCP (no. 350993), hamster anti-mouse CD11c-APC (no. 550261), mouse anti-mouse MCHII-FITC (no. MCA1501F; Serotec, Düsseldorf, Germany), rat anti-mouse CD86-FITC (no. 553691), hamster anti-mouse CD80-FITC (no. 553768), and hamster anti-mouse CD40-FITC (no. 553723).
For functional analysis, dentritic cells (DCs) from wt or Stim2 2/2 mice were prepared from BM cells flushed from femur and tibia bones as described before (19) . BM-derived DCs were harvested on day 8, and 2 3 10 6 cells in 1 ml splenocyte complete medium were incubated with 50 mg/ml MOG 35-55 for 6 h. Thereafter MOG 35-55 -loaded DCs (1 3 10 5 ) were cocultured with MACS isolated CD4 + T cells (5 3 10 5 ) (Miltenyi Biotec, Bergisch Gladbach, Germany) for 3 d, and supernatants were assessed for IFN-g and IL-17 levels by ELISA.
Blood values
At the end of the EAE experiment (day 50), whole blood was taken from three animals of each of the four experimental groups. Blood was centrifuged, and sera were analyzed for aspartate aminotransferase (GOT), alanine transaminase (GPT), glucose, and urea by spectrophotometric assays (Cobas Integra 800 auto-analyzer; Roche, Mannheim, Germany).
Immunohistochemistry
Paraformaldehyde-fixed spinal cord cryosections were stained with primary Ab (rat anti-CD3, 1:100, Serotec), secondary Ab (Cy3-labeled goat anti-rat 1:300; Dianova, Hamburg, Germany) and 0.5 mg/ml DAPI (Merck, Darmstadt, Germany). Pictures were collected by immunofluorescence microscopy (Axiophot; Zeiss, Jena, Germany). H&E and Luxol fast blue (LFB) stainings were done according to standard procedures.
Ca
2+ measurements in primary T cells CD4 + T cells were loaded with 5 mM Fura-2/AM (Invitrogen, Karlsruhe, Germany) in the presence of 0.2 mg/ml Pluronic F-127 (Invitrogen, Karlsruhe, Germany) for 30 min at 37˚C. After loading, T cells were washed twice and resuspended in calcium-free Tyrode's-HEPES buffer (134 mM NaCl, 0.34 mM Na 2 HPO 4 , 2.9 mM KCl, 12 mM NaHCO 3 , 20 mM HEPES [N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid], pH 7.0) containing 5 mM glucose, 0.35% BSA, and 2 mM CaCl 2 ). Stirred T cells were activated after 50 s equilibration time with 5 mM thapsigargin (Invitrogen) or, for TCR stimulation, cross-linking of anti-CD3e Abs (T cells were preincubated for 15 min with 10 mg/ml anti-CD3e Abs) with 10 mg/ml goat anti-hamster IgG Ab (Jackson ImmunoResearch, West Grove, PA) was used, and fluorescence was measured with a fluorimeter (LS 55; PerkinElmer). Excitation was alternated between 340 and 380 nm, and emission was measured at 509 nm. Each measurement was calibrated using Triton X-100 and EGTA.
Statistical analysis
All results are presented as mean 6 SEM. Statistical analysis was performed using a modified Student t test for parametric data (20) or a MannWhitney U test for nonparametric datasets. p values , 0.05 were considered statistically significant. pp , 0.05; ppp , 0.01; pppp , 0.001.
Results
To assess the role of the two STIM isoforms in EAE, we analyzed mice lacking either STIM1 or STIM2. Because STIM1 deficiency is associated with ∼70% perinatal lethality (17) , wt mice were transplanted with Stim1 2/2 BM and analyzed after 11 wk. In contrast, Stim2 2/2 mice were born apparently healthy, developed normally to adulthood, and were fertile. Starting at the age of 8 wk after birth, however, sudden death of Stim2 2/2 mice was observed, and only 10% of the mice reached the age of 7 mo (18) . Spontaneous death of Stim2 2/2 mice has also recently been reported by others (15) , although in this study, mice died by the age of 4 to 5 wk most likely due to variability in the genetic background of both strains. The absence of the targeted STIM isoforms in lymph nodes was confirmed by Western blot analysis (Fig. 1B, inset ). In agreement with previous reports (12, 15) , SOCE elicited by the sarcoplasmic/endoplasmic reticulum calcium ATPase inhibitor thapsigargin or anti-CD3 stimulation was virtually abolished in Stim1 2/2 T cells and significantly reduced in Stim2 2/2 T cells (Supplemental Fig. 1 ). In a first set of experiments, we examined the role of STIM1 in MOG 35-55 peptide-induced EAE (Fig. 1A, 1C ). Although eight of nine Stim1 2/2 chimeric animals (∼90%) were resistant to EAE, only one animal showed weak disease signs and was therefore excluded from further analysis (score at disease maximum for wt mice:
5.9 6 0.8; Fig. 1A , Table I ). Immunohistopathological analyses revealed no inflammatory lesions in the spinal cord of the mutant chimeras, whereas profound infiltrates and demyelination were seen in wt littermates (wt: 80.4 6 0.02%; Stim1 2/2 : 0%; p , 0.001; n = 4)
as identified by H&E and LFB staining for demyelination (Fig. 1C) .
A different picture emerged when Stim2 2/2 mice were subjected to the MOG EAE model. These animals displayed a significantly reduced disease maximum (wt: day 13.8; score: 6.4 6 0.8; Stim2 2/2 : day 15.2; score: 4.6 6 1.2; p , 0.05), whereas disease incidence, onset, overall disease course, and disease scores on day 50 were unaltered (Fig. 1B, Table I : 0.97 6 0.18%, p = 0.295; n = 3 each), but a comparable number of infiltrating T cells (Fig. 1D) .
Of note, routine laboratory parameters including GOT, GPT, glucose, and urea were evaluated at the end of the experiment and showed no differences between Stim1 2/2 chimeric, Stim2 2/2 , and control animals (Supplemental Table I ).
Absence of STIM1 or STIM2 influences cytokine secretion and proliferation under primary stimulation conditions Based on the above results, we assessed the influence of STIM deficiency on several immunological parameters. First, we examined T lymphocyte subset distribution in Stim1 2/2 chimeras and Stim2
mice compared with wt littermates by flow cytometry using CD4, CD8, CD44, and CD62L (21) as markers ( Fig. 2A, 2B ). Naive T cells express a CD62L high CD44 low phenotype, whereas memory T cells exhibit a CD62L low CD44 high phenotype. Analysis of CD62L and CD44 expression in naive splenocytes showed an increase in activated CD4 + CD62L low CD44 high T cells in Stim1 2/2 chimeric mice (wt: 30.9 6 3.46, n = 3; Stim1 2/2 : 58.9 6 5.47, n = 3, p , 0.05; Fig.   2A ; Supplemental Table II) as described previously (12) . To address the global functionality of knockout and wt immune cells, we stimulated isolated murine splenocytes with CD3/CD28 beads, a widely accepted method for polyclonal stimulation of lymphocytes. Naive Stim1 2/2 chimeric mice showed a significantly reduced secretion of the Th1 cytokines IFN-g (wt: 15,869 6 500 pg/ml, n = 8; Stim1 2/2 : 7,756 6 553 pg/ml, n = 9; p , 0.01) and IL-2 (wt: 8,756 6 612 pg/ml, n = 8; Stim1
2/2
: 4,150 6 803 pg/ml, n = 8; p , 0.01, Fig.  2C ). No change was observed for IL-17 (wt: 7,333 6 1464 pg/ml, n = 8; Stim1 2/2 : 8,231 6 688 pg/ml, n = 9; p . 0.05) and IL-10, whereas Stim1 2/2 cells showed significantly higher levels of the chimeric (E, gray column, n = 5), and Stim2 2/2 mice (F, gray column, n = 5) assessed by thymidine uptake upon CD3/CD28 bead stimulation. pp , 0.05; ppp , 0.01.
Th2 cytokines IL-4 and IL-5. This shift in the cytokine pattern was accompanied by an unaltered proliferation rate of naive splenocytes (wt: 10,338 6 1,300 cpm, n = 5; Stim1 2/2 : 9,373 6 1,263 cpm, n = 5; p . 0.05, Fig. 2E ).
No differences were observed between Stim2 2/2 and control mice (Fig. 2B ), both showing a large naive population (CD62L high CD44 low ). STIM2-deficient lymphocytes displayed no significant differences in the production of IFN-g and IL-2, but the secretion of IL-17 was markedly reduced compared with wt cells (wt: 10,042 6 3,187 pg/ml; Stim2 2/2 : 3,805 6 905 pg/ml, n = 8; p , 0.05; Fig. 2D ). Additionally, IL-5 levels were increased significantly in Stim2 2/2 lymphocytes, whereas no difference was found for IL-4 and IL-10. This was accompanied by a significantly reduced T cell proliferation rate (wt: 8,964 6 767 cpm, n = 5; Stim2 2/2 : 5,438 6 1,105 cpm, n = 5; p , 0.05, Fig. 2F ). The reduced ability of Stim2 2/2 cells to produce IL-17 ( Fig. 2D ) may be particularly relevant in the setting of EAE (Fig. 1B) , as Th17 cells are considered key pathogenic players in MOG-induced EAE.
Lack of STIM1 or STIM2 affects the generation of neuroantigen-specific T cell responses
Peripheral T lymphocyte subset distribution in EAE-induced Stim1 2/2 chimeric and Stim2 2/2 mice compared with wt littermates was assessed by flow cytometry using CD4, CD8, CD44, and CD62L as markers. No significant differences were observed (Fig. 3A, 3B ). We next assessed the quantity and quality of the T cell response following MOG immunization in mice. Splenocytes were isolated from Stim1 2/2 chimeric mice at disease maximum and stimulated with MOG. In this study, virtually no Ag-specific IFN-g production was detectable after MOG recall, indicating that the lack of this Ca 2+ sensor almost completely abolishes the generation of Ag-specific T cells. Comparable results were found for IL-2 and IL-17 (wt: 2,104 6 63 pg/ml, n = 5; Stim1 2/2 : 698 6 100 pg/ml, n = 5; p , 0.01). The latter stands in interesting contrast to the unaltered activation-induced production of IL-17 by naive CD3/CD28 activated cells, emphasizing a role of STIM1 for the generation of Ag-specific T cell responses in vivo (Fig. 3C) . Stim2 2/2 cells showed a significantly reduced Agspecific production of IFN-g and IL-17 and no significant change for IL-2 production (Fig. 3D) . In parallel to the deviated cytokine pattern, MOG-specific proliferation was reduced for both Stim1
and Stim2 2/2 splenocytes (Fig. 3C, 3D, insets) .
IL-17 ELISPOT assays were performed to investigate the Th17 response of Stim2 2/2 cells in EAE in more detail. Although Stim2
cells showed reduced levels of IL-17 production, the general number of IL-17-producing cells was not significantly altered ( p = 0.61; Fig.  3E ). However, the IL-17 output on the cellular level was significantly reduced in the absence of STIM2 (230%; p = 0.004; Fig. 3F ). Altogether, these results indicate that STIM-deficient mice undergo important changes in their cytokine phenotype upon immunization. Mice lacking STIM1 are virtually unable to raise a relevant Ag-specific T cell response against MOG. Both Th1 cytokines (IFN-g, IL-2) and, most importantly, IL-17 are strongly diminished, reflecting the resistance to EAE. In contrast, although showing the same tendencies on the cytokine level, Stim2 2/2 mice are able to generate more robust neuroantigen-specific T cell responses. This response, however, is attenuated because individual levels of IL-17 (and IFN-g) are significantly reduced.
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C D E F 4C-F) . This criss-cross approach clearly showed that neither STIM1 nor STIM2 deficiency had an effect on DC function, whereas significantly lower IFN-g and IL-17 production was detected in STIM1-and STIM2-deficient T cells compared with the wt controls.
Discussion
We investigated the role of STIM1 and STIM2 for T cell function and the generation of Ag-specific immune responses in a model of inflammation. We demonstrate that lack of STIM1-dependent SOCE severely impairs the generation of Ag-specific T cell responses in a MOG-induced EAE, resulting in resistance to disease development. The influence of STIM1 deficiency for T cell responses was demonstrated both on a qualitative as well as on a quantitative level. Lack of STIM2 resulted in a decreased, but not absent, SOCE in T cells and a significantly attenuated EAE course.
Although the effect of STIM2 deficiency on T cell responses was moderate compared with STIM1 deficiency, the lack of STIM2 influenced basal T cell-derived IL-17 production and the quantitative release of cytokines by individual Ag-specific T cells. We have previously shown that serum cytokine levels in naive wt and Stim1 2/2 mice are not significantly different (12) , whereas polyclonal in vitro stimulation (CD3/CD28), which results in much higher cytokine levels, revealed differences in T cell effector function caused by STIM deficiency. Although Stim1 2/2 chimeric mice are characterized by a lymphoproliferative phenotype despite normal thymic T cell maturation, the lack of SOCE results in significantly reduced cytokine production when T cells are stimulated with CD3/CD28 beads in vitro and an impaired cytokine production and proliferation when Ag-specific T cells are restimulated with their cognate Ag (Figs. 2C, 2D, 3C, 3D ). In our hands, Stim1 2/2 cells display unaltered proliferation capacities when stimulated maximally both via the TCR and CD28. It seems plausible that the effect of STIM deficiency depends on the strength of the activation signal and that it may be overcome by the Ca 2+ -independent costimulatory CD28 pathway (22) . Accordingly, despite the severe impairment of Ca 2+ signaling, Stim1 2/2 immune cells can generate acute graft-versus-host disease (aGVHD) (12) . aGVHD is primarily due to recipient-specific cytotoxic donor T lymphocytes, and the underlying cellular mechanisms differ from chronic GVHD, which has been shown to be caused by autoreactive helper T lymphocytes (23 + by flow cytometry for the surface markers MHCII, CD80, CD86, and CD40 revealed no significant differences between naive control and knockout mice (n = 3). C-F, Criss-cross experiment of DCs and T lymphocytes from wt (n = 4), Stim1 2/2 chimeric (n = 4), and and chronic non-MHC GVHD are caused by two different cellular mechanisms stimulated by different Ags (i.e., non-H-2 Ags in aGVHD and autologous Ia Ag in chronic GVHD). The EAE model is probably better comparable with chronic GVHD because of the relevance of autoreactive T cells resulting in chronic autoimmune-like symptoms (23, 24) . We therefore hypothesize that the capability of T cells to raise an adaptive immune response in the absence of STIM1 under certain conditions depends on the strength of the MHC-dependent TCR signal (possibly in combination with the comodulatory influence of accessory molecules and cytokine signals). Upon maximal in vitro stimulation with CD3/CD28 beads, we found an intact IL-17 response of Stim1 2/2 immune cells (Fig. 2C ), whereas T cell cytokine production was clearly impaired in Ag-specific T cells under recall conditions (Fig. 3C ). This residual competence of strongly optimal activated Stim1 2/2 immune cells might explain their relatively normal response in the aGVHD model. In contrast, the consequences of STIM2 deficiency for the generation of adaptive immune responses are rather mild, as revealed by the robust neuroantigen-specific T cell responses in Stim2 2/2 mice (Fig. 1B) . However, the strength (or quality) of this MOGspecific immune response is strongly diminished in comparison with wt at disease maximum (Fig. 3D, 3F ) underlining the impaired immune activation upon immunization at this time point. Furthermore, we found significantly reduced IL-17 production of Stim2 2/2 cells compared with wt control in response to both polyclonal stimulation with CD3/CD28 beads as well as Ag restimulation. In contrast, STIM2 deficiency had less influence on Th1 cytokines, albeit significantly lower IFN-g levels were observed at disease maximum. It is generally accepted that both Th1 and Th17 cells contribute to the development of EAE with Th17 cells being the first effector cells that invade the CNS during autoimmune inflammation (25, 26) . This might explain why the effect of STIM2 deficiency in the model of MOG-induced CNS inflammation was evident, especially at early stages of the disease. Thus, our data suggest that STIM2 deficiency affects the generation of adaptive T cell responses in vivo, which is most likely based on changes in cytokine patterns and levels. It is currently not clear how STIM2 function is mechanistically linked to the ability of T cells to secrete IL-17, but it is known that IL-17 expression depends especially on the calcium-regulated transcription factor NFAT (27) , whereas other cytokines might be less sensitive to subtle changes in calcium levels because of redundant pathways like MAPK or NF-kB. Of note, our data do not support a major role of STIM1 or STIM2 for the phenotype and Ag-presenting function of APCs (Fig. 4) . Thus, the observed effects in vivo are most likely explained by a specific effect of STIM deficiency on T cell function. It remains to be demonstrated, however, whether STIM molecules are involved in other mechanisms of T cell function beyond proliferation or cytokine secretion, such as migration of T cell subtypes to the CNS. The use of mice with T cellspecific STIM deficiencies may provide further detailed insights into these open questions. Taken together, we have shown that the lack of STIM1 in immune cells protects mice from the development of neuroantigen-specific T cell responses and therefore renders them resistant to EAE. In contrast, the lack of STIM2 leads to a reduced peak severity of EAE, possibly due to an effect of STIM2 on the individual IL-17 production by T cells. Therefore, STIM-regulated pathways represent novel interesting molecular target structures for the treatment of T cell-mediated autoimmune disorders.
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